Michael Schultz PhD is a founding member and CSO of Viewpoint. Dr. Schultz is also an Assistant Professor of Radiology at the University of Iowa. Dr. Schultz specializes in targeted diagnostic imaging and therapy for cancer. Dr. Schultz is experienced in IND submission to the FDA for approval of diagnostics and therapies, including the first gallium-68 labeled peptide for clinical human studies in the US and a successful IND for cancer therapy.

Heyward Coleman is Chief Executive Officer and a founding member of Viewpoint. Mr Coleman earned a MS in Nuclear Engineering from Duke University and an MBA from Harvard University. After a successful career in oil and gas, Mr. Coleman became a serial entrepreneur, founding the largest privately owned radiochemistry company in the US, among other projects. Mr Coleman directs operations, oversees finances, and manages strategic partnerships.

Frances Johnson MD is a founding member and Chief Medical Officer of Viewpoint. Dr Johnson's training includes an MD from University of Washington, residency at UC, San Francisco, followed by a fellowship and faculty appointment (Asst Prof) at Stanford. Dr Johnson has been involved in two successful biotech startups including XDx, Inc. Dr. Johnson is experienced in clinical trials and commercializing discoveries for diagnostics and therapies.

Ebrahim S. Delpassand MD is the founder and CEO of RadioMedix. Dr. Delpassand served 12 years as Deputy Chairman and Chief of Nuclear Medicine at the MD Anderson Cancer Center (University of TX), where he managed 65 technical staff and administrators and revenues of $50 million per year. Since that time Dr Delpassand has been a serial entrepreneur in healthcare and oncology, founding several successful businesses, most recently Radiomedix, Inc.

Dr. Graham is Professor and Vice Chair of Radiology and Director of Nuclear Medicine at the University of Iowa and is board certified. Dr. Graham's earned degrees from MIT (BSEE) and UC Berkeley (MSEE), followed by a PhD (Biophysics) from UC Berkeley, and MD from UCSF. He is past President of the Society of Nuclear Medicine and Co-Chair of the SNMMI Clinical Trials Network. Dr Graham has published over 178 papers, 9 chapters and 141 abstracts.